Lens ID,Title,Date Published,Publication Year,Publication Type,Source Title,ISSNs,Publisher,Source Country,Author/s,Abstract,Volume,Issue Number,Start Page,End Page,Fields of Study,Keywords,MeSH Terms,Chemicals,Funding,Source URLs,External URL,PMID,DOI,Microsoft Academic ID,PMCID,Citing Patents Count,References,Citing Works Count,Is Open Access,Open Access License,Open Access Colour
001-421-959-686-025,A scoping review of ontologies related to human behaviour change.,2019-01-14,2019,journal article,Nature human behaviour,23973374,Springer Science and Business Media LLC,England,Emma Norris; Ailbhe Finnerty; Janna Hastings; Gillian Stokes; Susan Michie,"Ontologies are classification systems specifying entities, definitions and inter-relationships for a given domain, with the potential to advance knowledge about human behaviour change. A scoping review was conducted to: (1) identify what ontologies exist related to human behaviour change, (2) describe the methods used to develop these ontologies and (3) assess the quality of identified ontologies. Using a systematic search, 2,303 papers were identified. Fifteen ontologies met the eligibility criteria for inclusion, developed in areas such as cognition, mental disease and emotions. Methods used for developing the ontologies were expert consultation, data-driven techniques and reuse of terms from existing taxonomies, terminologies and ontologies. Best practices used in ontology development and maintenance were documented. The review did not identify any ontologies representing the breadth and detail of human behaviour change. This suggests that advancing behavioural science would benefit from the development of a behaviour change intervention ontology.",3,2,164,172,Ontology (information science); Domain (software engineering); Cognition; Best practice; MEDLINE; Quality (business); Biological Ontologies; Computer science; Behavioural sciences; Knowledge management,,Behavior; Behavior Therapy/statistics & numerical data; Biological Ontologies/statistics & numerical data; Emotions; Humans; Mental Disorders; Mental Processes,,Medical Research Council (MR/L011115/1) United Kingdom,http://www.ncbi.nlm.nih.gov/pubmed/30944444 https://europepmc.org/article/MED/30944444 https://pubmed.ncbi.nlm.nih.gov/30944444/ https://bura.brunel.ac.uk/bitstream/2438/20803/1/FullText.pdf https://EconPapers.repec.org/RePEc:nat:nathum:v:3:y:2019:i:2:d:10.1038_s41562-018-0511-4 https://www.nature.com/articles/s41562-018-0511-4.pdf https://www.ncbi.nlm.nih.gov/pubmed/30944444 https://bura.brunel.ac.uk/handle/2438/20803 https://www.nature.com/articles/s41562-018-0511-4?WT.feed_name=subjects_social-science https://discovery.ucl.ac.uk/id/eprint/10067143/,http://dx.doi.org/10.1038/s41562-018-0511-4,30944444,10.1038/s41562-018-0511-4,2910583403,,0,000-729-525-748-481; 001-537-542-872-329; 001-606-605-674-140; 001-735-465-383-325; 003-337-166-503-154; 004-558-303-996-713; 005-225-291-076-135; 007-792-687-999-239; 010-455-944-815-287; 011-433-337-924-122; 011-763-996-915-504; 012-153-368-874-738; 013-303-277-111-046; 013-934-837-047-718; 014-669-050-721-686; 019-086-252-766-855; 022-248-774-147-186; 022-526-129-975-007; 024-448-092-072-841; 024-645-901-447-985; 028-863-725-493-173; 029-224-057-320-896; 030-927-038-896-618; 031-528-607-247-967; 033-284-531-419-850; 036-415-830-624-121; 046-349-456-344-014; 046-548-037-807-944; 050-125-566-480-721; 053-062-438-124-013; 053-897-221-267-692; 054-675-632-527-666; 057-897-961-024-835; 060-588-101-806-65X; 067-566-462-763-12X; 069-839-744-278-812; 070-267-981-329-358; 070-462-022-251-464; 072-117-231-915-218; 077-314-538-863-787; 081-660-536-174-95X; 082-243-214-348-506; 085-162-559-890-725; 085-771-160-054-008; 092-645-402-737-79X; 095-025-262-596-017; 096-395-508-164-949; 099-398-836-861-279; 100-840-528-972-746; 102-507-063-917-66X; 105-630-996-709-013; 109-847-606-550-637; 112-240-033-624-754; 119-280-642-397-527; 125-953-451-982-564; 127-245-670-262-773; 130-238-867-506-922; 131-423-542-523-282; 137-143-238-576-47X; 140-925-390-307-762; 164-749-032-502-104; 168-448-981-132-965,76,true,,green
001-606-605-674-140,The epidemiology ontology: an ontology for the semantic annotation of epidemiological resources,2014-01-17,2014,journal article,Journal of biomedical semantics,20411480,BioMed Central,United Kingdom,Catia Pesquita; João D. Ferreira; Francisco M. Couto; Mário J. Silva,"Epidemiology is a data-intensive and multi-disciplinary subject, where data integration, curation and sharing are becoming increasingly relevant, given its global context and time constraints. The semantic annotation of epidemiology resources is a cornerstone to effectively support such activities. Although several ontologies cover some of the subdomains of epidemiology, we identified a lack of semantic resources for epidemiology-specific terms. This paper addresses this need by proposing the Epidemiology Ontology (EPO) and by describing its integration with other related ontologies into a semantic enabled platform for sharing epidemiology resources. The EPO follows the OBO Foundry guidelines and uses the Basic Formal Ontology (BFO) as an upper ontology. The first version of EPO models several epidemiology and demography parameters as well as transmission of infection processes, participants and related procedures. It currently has nearly 200 classes and is designed to support the semantic annotation of epidemiology resources and data integration, as well as information retrieval and knowledge discovery activities. EPO is under active development and is freely available at https://code.google.com/p/epidemiology-ontology/;  . We believe that the annotation of epidemiology resources with EPO will help researchers to gain a better understanding of global epidemiological events by enhancing data integration and sharing.",5,1,4,4,Ontology (information science); Ontology-based data integration; Data science; Annotation; OBO Foundry; Context (language use); Basic Formal Ontology; Computer science; Data integration; Upper ontology,,,,,https://jbiomedsem.biomedcentral.com/articles/10.1186/2041-1480-5-4 https://link.springer.com/article/10.1186/2041-1480-5-4/fulltext.html https://pubmed.ncbi.nlm.nih.gov/24438387/ https://www.ncbi.nlm.nih.gov/pubmed/24438387 https://core.ac.uk/display/81077188 https://link.springer.com/content/pdf/10.1186%2F2041-1480-5-4.pdf http://www.jbiomedsem.com/content/5/1/4 http://www.jbiomedsem.com/content/pdf/2041-1480-5-4.pdf http://dx.doi.org/10.1186/2041-1480-5-4 https://dx.doi.org/10.1186/2041-1480-5-4 http://dblp.uni-trier.de/db/journals/biomedsem/biomedsem5.html#PesquitaFCS14 https://europepmc.org/article/MED/24438387 https://link.springer.com/article/10.1186/2041-1480-5-4,http://dx.doi.org/10.1186/2041-1480-5-4,24438387,10.1186/2041-1480-5-4,2107712133,PMC3926306,0,002-098-090-197-32X; 004-267-564-402-039; 008-914-701-728-582; 010-706-041-385-275; 013-073-632-111-26X; 020-610-858-222-303; 024-645-901-447-985; 026-252-081-638-000; 030-791-242-311-808; 037-754-251-381-56X; 043-962-061-878-739; 044-056-610-413-080; 046-809-560-040-904; 047-843-912-914-122; 051-806-488-023-428; 051-855-287-652-173; 053-291-522-909-699; 058-888-617-034-219; 059-357-302-827-12X; 068-428-508-024-519; 069-015-203-609-840; 078-031-035-558-808; 082-243-214-348-506; 083-170-397-924-722; 088-886-967-322-295; 093-591-420-745-959; 099-398-836-861-279; 109-499-256-315-400; 112-240-033-624-754; 116-574-261-437-956; 133-488-347-540-693; 134-501-065-575-61X; 138-896-458-602-652,24,true,"CC BY, CC0",gold
001-967-591-035-228,Visualization and analytics tools for infectious disease epidemiology,2014-04-16,2014,journal article,Journal of biomedical informatics,15320480; 15320464,Academic Press Inc.,United States,Lauren N. Carroll; Alan P. Au; Landon T. Detwiler; Tsung-chieh Fu; Ian Painter; Neil F. Abernethy,"Graphical abstractDisplay Omitted Visualization tools for infectious disease epidemiology are diverse.Complex geospatial, molecular, and social data require novel visualization tools.We reviewed visualization tools throughout development and adoption lifecycle.Visualization tools vary in usability and many suffer limited adoption.Challenges include data quality, access, and limits of human cognition and technology. BackgroundA myriad of new tools and algorithms have been developed to help public health professionals analyze and visualize the complex data used in infectious disease control. To better understand approaches to meet these users' information needs, we conducted a systematic literature review focused on the landscape of infectious disease visualization tools for public health professionals, with a special emphasis on geographic information systems (GIS), molecular epidemiology, and social network analysis. The objectives of this review are to: (1) identify public health user needs and preferences for infectious disease information visualization tools; (2) identify existing infectious disease information visualization tools and characterize their architecture and features; (3) identify commonalities among approaches applied to different data types; and (4) describe tool usability evaluation efforts and barriers to the adoption of such tools. MethodsWe identified articles published in English from January 1, 1980 to June 30, 2013 from five bibliographic databases. Articles with a primary focus on infectious disease visualization tools, needs of public health users, or usability of information visualizations were included in the review. ResultsA total of 88 articles met our inclusion criteria. Users were found to have diverse needs, preferences and uses for infectious disease visualization tools, and the existing tools are correspondingly diverse. The architecture of the tools was inconsistently described, and few tools in the review discussed the incorporation of usability studies or plans for dissemination. Many studies identified concerns regarding data sharing, confidentiality and quality. Existing tools offer a range of features and functions that allow users to explore, analyze, and visualize their data, but the tools are often for siloed applications. Commonly cited barriers to widespread adoption included lack of organizational support, access issues, and misconceptions about tool use. Discussion and conclusionAs the volume and complexity of infectious disease data increases, public health professionals must synthesize highly disparate data to facilitate communication with the public and inform decisions regarding measures to protect the public's health. Our review identified several themes: consideration of users' needs, preferences, and computer literacy; integration of tools into routine workflow; complications associated with understanding and use of visualizations; and the role of user trust and organizational support in the adoption of these tools. Interoperability also emerged as a prominent theme, highlighting challenges associated with the increasingly collaborative and interdisciplinary nature of infectious disease control and prevention. Future work should address methods for representing uncertainty and missing data to avoid misleading users as well as strategies to minimize cognitive overload.",51,,287,298,Usability; Information visualization; Disparate system; Data science; Data sharing; Infectious Disease Epidemiology; Visualization; Computer science; Information needs; Analytics,Disease surveillance; GIS; Infectious disease; Public health; Social network analysis; Visualization,"Communicable Disease Control/methods; Communicable Diseases/epidemiology; Geographic Information Systems; Geographic Mapping; Humans; Molecular Epidemiology/methods; Population Surveillance/methods; Social Networking; Software; Spatio-Temporal Analysis; Technology Assessment, Biomedical; User-Computer Interface",,NLM NIH HHS (R01 LM011180) United States; NLM NIH HHS (R01LM011180) United States,https://www.sciencedirect.com/science/article/pii/S1532046414000914 https://dl.acm.org/doi/10.1016/j.jbi.2014.04.006 https://pubmed.ncbi.nlm.nih.gov/24747356/ https://dblp.uni-trier.de/db/journals/jbi/jbi51.html#CarrollADFPA14 https://europepmc.org/article/MED/24747356 https://core.ac.uk/display/82170198 http://dx.doi.org/10.1016/j.jbi.2014.04.006 https://dx.doi.org/10.1016/j.jbi.2014.04.006 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734643,http://dx.doi.org/10.1016/j.jbi.2014.04.006,24747356,10.1016/j.jbi.2014.04.006,2151103962,PMC5734643,1,001-238-289-927-372; 001-775-042-221-291; 002-706-266-659-978; 003-269-564-434-180; 003-872-481-341-305; 005-364-141-022-860; 005-447-583-090-16X; 006-342-405-551-950; 006-664-111-086-821; 007-132-715-516-465; 008-971-607-014-664; 009-800-703-983-633; 010-177-982-154-70X; 010-192-196-585-364; 010-330-816-093-815; 012-364-473-929-964; 012-575-442-088-47X; 013-541-969-076-695; 013-720-227-822-234; 014-460-130-801-929; 016-476-333-089-627; 017-174-131-102-697; 017-300-737-144-757; 017-629-905-968-960; 017-925-867-349-70X; 018-024-437-950-384; 018-217-706-097-053; 018-311-549-268-269; 019-006-261-382-594; 020-030-368-061-083; 020-873-935-341-379; 021-399-412-745-885; 023-204-472-874-283; 025-525-299-512-800; 026-645-630-002-222; 027-552-860-986-224; 029-184-567-030-350; 029-305-924-416-306; 029-359-636-471-902; 030-873-518-814-887; 030-928-755-984-666; 032-122-845-844-616; 032-399-923-411-149; 032-493-797-530-702; 032-525-185-446-220; 032-803-075-636-434; 033-151-986-391-20X; 033-605-865-391-055; 034-451-747-861-893; 035-721-412-322-605; 036-227-311-441-202; 036-447-441-855-918; 037-434-903-430-679; 038-572-528-960-062; 039-450-732-624-382; 039-670-494-229-639; 040-148-545-247-997; 040-340-551-633-106; 040-692-269-309-424; 041-475-224-994-160; 041-686-494-383-079; 043-668-475-224-797; 047-269-456-641-648; 048-252-804-718-273; 048-287-502-132-269; 049-536-441-753-811; 051-798-090-690-354; 052-005-743-409-376; 053-932-247-671-416; 054-301-452-430-297; 057-078-515-047-667; 057-736-676-654-048; 057-994-226-204-949; 058-081-424-637-980; 058-824-518-612-746; 060-851-630-056-693; 061-010-150-461-294; 062-112-768-963-759; 062-225-002-567-577; 062-526-304-605-777; 063-311-294-495-284; 064-915-831-884-562; 066-006-658-272-419; 066-586-344-667-868; 067-308-000-369-644; 067-402-396-484-112; 068-732-063-528-429; 069-733-146-796-307; 069-774-631-576-851; 071-646-824-429-546; 073-927-898-685-466; 075-469-875-221-842; 076-588-701-664-350; 076-863-036-625-717; 078-141-049-979-045; 078-209-127-067-665; 080-674-170-290-462; 081-038-526-552-750; 083-131-431-018-60X; 083-275-795-865-394; 086-392-099-717-437; 087-323-174-491-915; 087-392-145-197-767; 087-919-550-240-624; 088-195-522-205-042; 088-695-958-872-98X; 089-301-573-327-886; 089-978-773-177-91X; 091-661-275-133-785; 092-197-102-933-864; 093-785-891-047-079; 095-005-325-832-438; 096-506-393-582-890; 097-693-749-109-379; 100-016-372-318-258; 103-435-087-102-541; 106-088-859-051-226; 106-195-102-586-011; 106-960-761-190-016; 108-520-811-106-155; 109-954-781-425-036; 110-309-926-544-567; 111-075-959-145-279; 112-240-033-624-754; 114-324-744-366-799; 116-690-620-281-956; 116-944-744-819-436; 117-782-375-820-462; 119-586-051-593-755; 124-437-075-376-677; 127-566-683-855-532; 128-132-282-797-392; 129-138-828-407-901; 133-488-347-540-693; 135-351-388-942-600; 136-288-669-107-676; 136-880-811-885-640; 138-322-151-335-278; 141-533-514-018-676; 145-113-288-221-434; 146-718-800-391-271; 147-532-859-378-937; 150-247-080-675-28X; 150-325-162-873-23X; 160-850-720-295-197; 163-637-734-144-951; 168-454-575-013-531; 168-822-698-047-105; 186-571-257-791-640; 193-126-027-125-288,149,true,cc-by-nc-sa,hybrid
002-916-323-177-98X,ICBO - Bringing epidemiology into the Semantic Web.,,2012,book,,,,,João D. Ferreira; Catia Pesquita; Francisco M. Couto; Mário J. Silva,"Epidemiology is a domain of knowledge interconnected with many other domains, thus making it a good candidate for reusing existing ontologies that, despite having been created for different purposes, characterize information frequently manipulated by epidemiologists and public health scientists. This paper presents an evaluation of existing ontologies for the semantic annotation of epidemiological resources. We selected a set of ontologies and proposed a Network of Epidemiology-Related Ontologies (NERO), which can form the core of semantic annotation for data-intensive epidemiology-related information systems, such as epidemic forecasting infrastructures. To support this selection, we defined a set of requirements for inclusion of ontologies in NERO, based on good ontology practice, the interdisciplinary nature of the epidemiological domain and support of semantic web technologies. Most of the selected NERO ontologies are current candidates or members of the Open Biological and Biomedical Ontologies initiative.",,,,,World Wide Web; Open Biomedical Ontologies; Semantic analytics; Ontology (information science); Semantic Web Stack; Domain (software engineering); Information system; Semantic Web; Computer science; Social Semantic Web,,,,,http://webpages.fc.ul.pt/~fjcouto/files/conference%20jferreira-icbo2012.pdf http://www.academia.edu/2736556/Bringing_epidemiology_into_the_Semantic_Web http://kr-med.org/icbofois2012/proceedings/ICBO2012/ICBO2012PapersSingleFiles/ICBO-2012-session1-paper02-ferreira.pdf http://ceur-ws.org/Vol-897/session1-paper02.pdf,http://webpages.fc.ul.pt/~fjcouto/files/conference%20jferreira-icbo2012.pdf,,,2405721538,,0,001-437-814-415-087; 004-267-564-402-039; 011-831-311-825-058; 013-073-632-111-26X; 015-593-478-724-237; 024-645-901-447-985; 028-427-172-828-859; 029-838-004-406-596; 046-611-915-478-048; 047-864-793-002-106; 051-855-287-652-173; 057-302-771-005-275; 068-428-508-024-519; 093-654-471-983-32X; 094-793-082-519-562; 112-240-033-624-754; 113-308-406-790-347; 116-574-261-437-956; 127-454-161-047-283; 129-440-932-878-09X; 134-501-065-575-61X; 138-070-179-191-239; 143-441-767-976-48X; 157-891-448-159-526; 174-811-057-209-905,9,false,,
012-538-246-172-815,A systematic review of spatial decision support systems in public health informatics supporting the identification of high risk areas for zoonotic disease outbreaks,2018-10-30,2018,journal article,International journal of health geographics,1476072x,BioMed Central,United Kingdom,Rachel Beard; Elizabeth A. Wentz; Matthew Scotch,"Zoonotic diseases account for a substantial portion of infectious disease outbreaks and burden on public health programs to maintain surveillance and preventative measures. Taking advantage of new modeling approaches and data sources have become necessary in an interconnected global community. To facilitate data collection, analysis, and decision-making, the number of spatial decision support systems reported in the last 10 years has increased. This systematic review aims to describe characteristics of spatial decision support systems developed to assist public health officials in the management of zoonotic disease outbreaks. A systematic search of the Google Scholar database was undertaken for published articles written between 2008 and 2018, with no language restriction. A manual search of titles and abstracts using Boolean logic and keyword search terms was undertaken using predefined inclusion and exclusion criteria. Data extraction included items such as spatial database management, visualizations, and report generation. For this review we screened 34 full text articles. Design and reporting quality were assessed, resulting in a final set of 12 articles which were evaluated on proposed interventions and identifying characteristics were described. Multisource data integration, and user centered design were inconsistently applied, though indicated diverse utilization of modeling techniques. The characteristics, data sources, development and modeling techniques implemented in the design of recent SDSS that target zoonotic disease outbreak were described. There are still many challenges to address during the design process to effectively utilize the value of emerging data sources and modeling methods. In the future, development should adhere to comparable standards for functionality and system development such as user input for system requirements, and flexible interfaces to visualize data that exist on different scales. PROSPERO registration number: CRD42018110466.",17,1,38,38,Public health informatics; Decision support system; Data collection; Health informatics; User-centered design; Spatial database; Data science; Data extraction; Computer science; Data integration,Decision making  computer-assisted; Public health informatics; Spatial decision support systems; Zoonoses,Animals; Decision Making; Decision Support Techniques; Disease Outbreaks/prevention & control; Humans; Public Health Informatics/methods; Risk Factors; Zoonoses/diagnosis,,NLM NIH HHS (F31 LM012176) United States; NLM NIH HHS (R01 LM012080) United States,https://pubmed.ncbi.nlm.nih.gov/30376842/ https://link.springer.com/article/10.1186/s12942-018-0157-5 https://ij-healthgeographics.biomedcentral.com/articles/10.1186/s12942-021-00293-x https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386034 https://europepmc.org/article/MED/30376842 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208014 https://asu.pure.elsevier.com/en/publications/a-systematic-review-of-spatial-decision-support-systems-in-public https://link.springer.com/content/pdf/10.1186/s12942-018-0157-5.pdf,http://dx.doi.org/10.1186/s12942-018-0157-5,30376842,10.1186/s12942-018-0157-5,2898845830,PMC6208014,0,000-755-971-812-411; 001-238-289-927-372; 001-300-850-257-939; 001-471-970-449-659; 001-775-042-221-291; 001-967-591-035-228; 002-322-745-805-677; 003-197-876-514-155; 003-872-481-341-305; 005-244-119-602-109; 005-610-711-946-397; 006-830-208-128-312; 008-770-954-435-323; 008-882-777-725-317; 010-745-949-530-702; 011-836-234-593-38X; 012-214-743-908-909; 013-873-201-911-412; 014-364-377-181-59X; 014-667-185-528-489; 014-898-012-188-314; 015-043-336-817-386; 015-046-825-344-894; 015-488-244-936-777; 017-629-905-968-960; 019-521-328-408-530; 020-958-578-102-259; 021-767-652-804-609; 021-944-720-672-500; 022-783-868-536-558; 022-999-318-530-859; 023-311-500-249-850; 023-749-243-206-484; 024-198-858-608-381; 025-197-911-266-045; 026-344-328-456-478; 026-351-807-903-912; 026-450-263-078-021; 027-027-955-942-667; 028-124-484-669-078; 028-545-837-629-393; 031-139-518-653-18X; 031-903-615-544-111; 032-803-075-636-434; 033-027-759-786-051; 033-048-286-583-31X; 033-963-775-549-138; 035-167-341-947-943; 035-526-584-758-030; 035-623-039-495-516; 035-922-075-100-825; 036-010-631-962-667; 036-540-413-498-681; 036-877-116-878-307; 037-473-058-458-093; 037-853-897-095-224; 038-087-456-440-99X; 038-246-736-945-381; 039-343-259-048-864; 039-394-464-129-022; 040-340-551-633-106; 040-833-551-383-122; 041-405-652-024-562; 041-475-224-994-160; 041-948-493-818-031; 043-288-194-399-772; 044-975-631-919-440; 046-161-861-908-800; 047-003-809-706-745; 047-229-121-484-621; 047-254-748-571-686; 047-506-819-333-692; 049-536-441-753-811; 049-542-426-097-669; 050-676-285-992-879; 050-719-277-820-660; 051-275-682-667-745; 053-062-438-124-013; 053-425-106-961-552; 054-315-379-967-043; 054-570-085-193-263; 055-164-179-317-899; 057-092-620-569-628; 057-292-647-053-96X; 057-545-918-303-995; 057-736-676-654-048; 057-959-262-200-933; 061-571-927-744-518; 062-118-822-434-856; 062-206-763-349-933; 063-311-294-495-284; 063-685-329-635-205; 063-846-009-418-548; 064-752-248-343-079; 064-803-507-719-059; 066-586-344-667-868; 066-996-712-012-198; 067-003-844-339-341; 067-402-396-484-112; 067-884-641-869-986; 068-357-718-828-632; 068-715-355-096-256; 069-317-623-747-864; 069-675-124-832-132; 069-733-146-796-307; 069-814-570-041-514; 071-505-364-862-103; 071-644-950-772-557; 071-705-199-485-645; 072-313-035-959-967; 073-761-459-102-217; 076-863-036-625-717; 076-921-259-528-036; 077-861-810-615-735; 079-443-090-203-871; 079-910-493-000-876; 081-854-877-866-896; 083-826-851-189-326; 085-727-976-643-595; 086-427-445-455-386; 086-583-894-039-518; 090-112-323-252-933; 092-492-017-238-498; 093-283-039-771-352; 094-803-481-788-897; 095-427-485-104-210; 095-838-114-146-610; 097-693-749-109-379; 099-993-498-730-415; 100-932-578-020-258; 101-816-943-690-400; 104-959-715-158-313; 108-073-371-343-314; 112-240-033-624-754; 113-204-120-885-889; 113-414-129-329-542; 113-970-614-729-256; 123-011-163-734-660; 129-101-681-354-569; 130-332-700-979-390; 132-038-486-515-266; 133-378-911-810-117; 140-466-987-971-746; 141-533-514-018-676; 146-552-172-552-881; 154-383-920-227-01X; 156-289-548-612-924; 158-675-713-708-734; 161-827-585-164-039; 184-707-385-534-89X,16,true,"CC BY, CC0",gold
013-657-846-073-94X,IRI - Ontology-Based Supervised Concept Learning for the Biogeochemical Literature,,2018,conference proceedings article,2018 IEEE International Conference on Information Reuse and Integration (IRI),,IEEE,,Deya Banisakher; Maria Presa Reyes; Joshua D. Eisengberg; Joshua M. Allen; Mark A. Finlayson; René M. Price; Shu-Ching Chen,"Academic literature search is a vital step of every research project, especially in the face of the increasingly rapid growth of scientific knowledge. Semantic academic literature search is an approach to scientific article retrieval and ranking using concepts in an attempt to address well-known deficiencies of keyword-based search. The difficulty of semantic search, however, is that it requires significant knowledge engineering, often in the form of conceptual ontologies tailored to a particular scientific domain. It also requires non-trivial tuning, in the form of domain-specific term and concepts weights. As part of an ongoing project seeking to build a domain-specific semantic search system, we present an ontology-based supervised concept learning approach for the biogeochemical scientific literature. We first discuss the creation of a dataset of scientific articles in the biogeochemical domain annotated using the Environment Ontology (ENVO). Next we present a supervised machine learning classifier-a random decision forest-that uses a distinctive set of features to learn ENVO concepts and then label and index scientific articles at the sentence level. Finally, we evaluate our approach against two baseline methods, keyword-based and bag-of-words, achieving an overall performance of 0.76 F_1 measure, an improvement of approximately 50%.",,,402,410,Semantic search; Ontology (information science); Ranking (information retrieval); Sociology of scientific knowledge; Information retrieval; Scientific literature; Computer science; Concept learning; Search engine indexing; Knowledge engineering,,,,,https://dblp.uni-trier.de/db/conf/iri/iri2018.html#BanisakherREAFP18 https://doi.org/10.1109/IRI.2018.00066 https://www.computer.org/csdl/proceedings-article/iri/2018/265901a402/12OmNxdm4FI https://ieeexplore.ieee.org/document/8424737/authors,http://dx.doi.org/10.1109/iri.2018.00066,,10.1109/iri.2018.00066,2885073268,,0,000-524-338-757-738; 004-042-212-449-442; 004-446-332-271-977; 004-562-487-736-159; 006-101-714-460-131; 009-020-564-771-675; 010-639-046-831-29X; 013-440-555-714-981; 019-356-887-507-125; 022-680-619-027-814; 024-592-178-769-048; 026-259-712-932-233; 026-977-890-294-023; 029-475-734-919-895; 030-487-147-524-374; 031-996-508-042-605; 032-569-118-055-742; 032-966-378-714-774; 035-727-159-487-146; 037-413-978-142-214; 041-356-495-352-694; 041-503-990-213-605; 043-200-166-634-027; 043-253-148-579-019; 045-163-375-516-257; 055-709-566-196-991; 059-645-631-899-796; 062-213-533-624-448; 086-294-736-427-784; 097-485-318-728-585; 097-494-112-757-262; 099-169-442-324-498; 107-487-023-328-277; 112-240-033-624-754; 113-282-189-361-219; 119-755-856-021-812; 120-332-905-199-328; 122-720-708-824-937; 134-213-804-511-155; 137-185-622-456-072; 138-524-726-369-985; 158-990-269-046-307,0,false,,
018-203-096-520-098,The environment ontology: contextualising biological and biomedical entities,2013-12-11,2013,journal article,Journal of biomedical semantics,20411480,BioMed Central,United Kingdom,Pier Luigi Buttigieg; Norman Morrison; Barry Smith; Christopher J. Mungall; Suzanna E. Lewis,"As biological and biomedical research increasingly reference the environmental context of the biological entities under study, the need for formalisation and standardisation of environment descriptors is growing. The Environment Ontology (ENVO; http://www.environmentontology.org) is a community-led, open project which seeks to provide an ontology for specifying a wide range of environments relevant to multiple life science disciplines and, through an open participation model, to accommodate the terminological requirements of all those needing to annotate data using ontology classes. This paper summarises ENVO’s motivation, content, structure, adoption, and governance approach. The ontology is available from http://purl.obolibrary.org/obo/envo.owl - an OBO format version is also available by switching the file suffix to “obo”.",4,1,43,43,Process ontology; Open Biomedical Ontologies; Ontology (information science); Ontology-based data integration; Data science; Context (language use); Computer science; Suggested Upper Merged Ontology; Upper ontology; Information science,,,,NHGRI NIH HHS (U54 HG004028) United States,http://www.jbiomedsem.com/content/4/1/43/abstract https://link.springer.com/article/10.1186/2041-1480-4-43 https://epic.awi.de/id/eprint/43649/ https://philpapers.org/rec/BUTTEO-3 http://europepmc.org/articles/PMC3904460 https://jbiomedsem.biomedcentral.com/articles/10.1186/2041-1480-4-43 https://philpapers.org/archive/BUTTEO-3.pdf http://www.jbiomedsem.com/content/4/1/43 http://dx.doi.org/10.1186/2041-1480-4-43 https://dx.doi.org/10.1186/2041-1480-4-43 https://link.springer.com/content/pdf/10.1186%2F2041-1480-4-43.pdf https://core.ac.uk/download/78485107.pdf,http://dx.doi.org/10.1186/2041-1480-4-43,24330602,10.1186/2041-1480-4-43,2097877306,PMC3904460,0,000-811-948-275-375; 002-033-208-632-853; 002-788-723-850-295; 008-333-354-853-972; 008-895-861-187-411; 011-420-602-644-621; 013-006-571-464-95X; 013-563-615-485-907; 014-803-149-314-372; 016-424-651-302-791; 024-127-947-400-533; 024-645-901-447-985; 026-259-712-932-233; 026-593-641-985-541; 027-095-783-245-21X; 027-215-840-985-067; 032-648-092-008-678; 032-843-941-944-115; 033-571-620-925-634; 040-422-354-187-206; 040-955-246-990-300; 043-106-349-021-695; 043-987-140-955-748; 044-104-560-227-848; 050-190-801-373-266; 054-007-645-941-707; 067-014-567-961-944; 069-015-203-609-840; 073-678-570-467-903; 076-805-256-042-710; 079-082-069-729-819; 083-295-041-441-649; 086-005-841-858-822; 091-548-711-463-541; 094-276-813-896-009; 095-697-695-786-782; 100-840-528-972-746; 104-139-905-056-365; 108-375-064-455-045; 109-313-323-939-363; 112-240-033-624-754; 119-745-547-498-423; 130-393-709-183-70X,205,true,"CC BY, CC0",gold
020-302-769-945-142,DNA Methods in Food Safety: Molecular Typing of Foodborne and Waterborne Bacterial Pathogens - Databases and Internet Applications,2014-08-29,2014,book,DNA Methods in Food Safety,,"John Wiley & Sons, Ltd",,Gopal R. Gopinath; K. Hari; R. Jain; Mahendra H. Kothary; Karen G. Jarvis; A. A. Franco; Christopher J. Grim; Venugopal Sathyamoorthy; Mark K. Mammel; Atin R. Datta; B. A. McCardell; M. D. Solomotis; Ben D. Tall,,,,113,132,The Internet; World Wide Web; Computer science; Database,,,,,http://onlinelibrary.wiley.com/doi/10.1002/9781118278666.ch6/pdf,http://dx.doi.org/10.1002/9781118278666.ch6,,10.1002/9781118278666.ch6,1534129490,,0,004-045-907-370-339; 004-184-940-485-832; 004-366-517-549-162; 006-638-206-125-919; 008-748-602-939-156; 008-962-875-227-514; 010-224-778-985-302; 011-874-787-988-696; 012-241-524-245-635; 015-225-493-695-535; 015-930-489-228-313; 016-315-130-217-847; 016-812-841-007-907; 021-762-955-946-871; 021-874-228-188-564; 022-499-883-834-82X; 022-914-664-076-85X; 024-547-739-203-405; 028-508-265-170-595; 029-640-505-327-016; 030-203-232-825-14X; 032-401-573-898-929; 033-207-846-396-973; 035-413-713-963-081; 035-849-324-143-052; 036-419-584-713-10X; 037-591-021-884-352; 038-326-807-036-83X; 046-511-889-612-849; 047-570-390-544-636; 057-901-192-811-824; 066-586-957-648-010; 067-184-566-355-944; 081-589-879-516-422; 112-240-033-624-754; 132-499-650-509-717; 140-241-565-594-541; 146-225-248-240-852; 186-935-818-527-298,0,false,,
024-312-992-411-447,MetaBar - a tool for consistent contextual data acquisition and standards compliant submission,2010-06-30,2010,journal article,BMC bioinformatics,14712105,BioMed Central,United Kingdom,Wolfgang Hankeln; Pier Luigi Buttigieg; Dennis Fink; Renzo Kottmann; Pelin Yilmaz; Frank Oliver Glöckner,"Environmental sequence datasets are increasing at an exponential rate; however, the vast majority of them lack appropriate descriptors like sampling location, time and depth/altitude: generally referred to as metadata or contextual data. The consistent capture and structured submission of these data is crucial for integrated data analysis and ecosystems modeling. The application MetaBar has been developed, to support consistent contextual data acquisition. MetaBar is a spreadsheet and web-based software tool designed to assist users in the consistent acquisition, electronic storage, and submission of contextual data associated to their samples. A preconfigured Microsoft® Excel® spreadsheet is used to initiate structured contextual data storage in the field or laboratory. Each sample is given a unique identifier and at any stage the sheets can be uploaded to the MetaBar database server. To label samples, identifiers can be printed as barcodes. An intuitive web interface provides quick access to the contextual data in the MetaBar database as well as user and project management capabilities. Export functions facilitate contextual and sequence data submission to the International Nucleotide Sequence Database Collaboration (INSDC), comprising of the DNA DataBase of Japan (DDBJ), the European Molecular Biology Laboratory database (EMBL) and GenBank. MetaBar requests and stores contextual data in compliance to the Genomic Standards Consortium specifications. The MetaBar open source code base for local installation is available under the GNU General Public License version 3 (GNU GPL3). The MetaBar software supports the typical workflow from data acquisition and field-sampling to contextual data enriched sequence submission to an INSDC database. The integration with the megx.net marine Ecological Genomics database and portal facilitates georeferenced data integration and metadata-based comparisons of sampling sites as well as interactive data visualization. The ample export functionalities and the INSDC submission support enable exchange of data across disciplines and safeguarding contextual data.",11,1,358,358,Data visualization; Workflow; Database server; Field (computer science); Computer science; Contextual design; Database; Metadata,,"Base Sequence; Databases, Genetic; Genomics; Information Storage and Retrieval/methods; Internet; Programming Languages; Software; User-Computer Interface; Workflow",,,https://dblp.uni-trier.de/db/journals/bmcbi/bmcbi11.html#HankelnBFKYG10 https://paperity.org/p/56802498/metabar-a-tool-for-consistent-contextual-data-acquisition-and-standards-compliant https://www.biomedcentral.com/1471-2105/11/358/abstract https://dx.doi.org/10.1186/1471-2105-11-358 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912304/ https://doi.org/10.1186/1471-2105-11-358 http://dx.doi.org/10.1186/1471-2105-11-358 https://link.springer.com/article/10.1186%2F1471-2105-11-358 http://europepmc.org/articles/PMC2912304 https://doaj.org/article/f31713be93784ba1890eb0e215c5c16e https://link.springer.com/content/pdf/10.1186%2F1471-2105-11-358.pdf https://bmcbioinformatics.biomedcentral.com/articles/10.1186/1471-2105-11-358 https://pure.mpg.de/pubman/item/item_2485059_2/component/file_3265365/Hankeln10.pdf https://0-bmcbioinformatics-biomedcentral-com.brum.beds.ac.uk/articles/10.1186/1471-2105-11-358,http://dx.doi.org/10.1186/1471-2105-11-358,20591175,10.1186/1471-2105-11-358,2046485931,PMC2912304,0,006-043-193-943-45X; 008-224-784-496-888; 009-005-868-049-133; 009-870-648-127-378; 010-756-430-623-447; 012-503-201-682-416; 021-846-597-556-926; 024-345-306-084-468; 024-762-006-927-555; 032-243-295-012-217; 032-803-075-636-434; 043-106-349-021-695; 045-984-330-229-025; 049-177-306-337-493; 068-462-864-388-414; 068-697-673-980-091; 069-279-293-364-208; 069-656-327-824-155; 078-490-603-019-750; 079-751-866-864-146; 083-295-041-441-649; 112-240-033-624-754; 123-919-620-461-216; 128-297-412-074-447; 165-045-523-049-130,11,true,"CC BY, CC0",gold
027-043-209-622-805,"CDinFusion – Submission-Ready, On-Line Integration of Sequence and Contextual Data",2011-09-13,2011,journal article,PloS one,19326203,Public Library of Science,United States,Wolfgang Hankeln; Norma Johanna Wendel; Jan E. Gerken; Jost Waldmann; Pier Luigi Buttigieg; Ivaylo Kostadinov; Renzo Kottmann; Pelin Yilmaz; Frank Oliver Glöckner,"State of the art (DNA) sequencing methods applied in “Omics” studies grant insight into the ‘blueprints’ of organisms from all domains of life. Sequencing is carried out around the globe and the data is submitted to the public repositories of the International Nucleotide Sequence Database Collaboration. However, the context in which these studies are conducted often gets lost, because experimental data, as well as information about the environment are rarely submitted along with the sequence data. If these contextual or metadata are missing, key opportunities of comparison and analysis across studies and habitats are hampered or even impossible. To address this problem, the Genomic Standards Consortium (GSC) promotes checklists and standards to better describe our sequence data collection and to promote the capturing, exchange and integration of sequence data with contextual data. In a recent community effort the GSC has developed a series of recommendations for contextual data that should be submitted along with sequence data. To support the scientific community to significantly enhance the quality and quantity of contextual data in the public sequence data repositories, specialized software tools are needed. In this work we present CDinFusion, a web-based tool to integrate contextual and sequence data in (Multi)FASTA format prior to submission. The tool is open source and available under the Lesser GNU Public License 3. A public installation is hosted and maintained at the Max Planck Institute for Marine Microbiology at http://www.megx.net/cdinfusion. The tool may also be installed locally using the open source code available at http://code.google.com/p/cdinfusion.",6,9,e24797,,FASTA format; World Wide Web; Sequence Read Archive; Software; Context (language use); License; Experimental data; Bioinformatics; Contextual design; Biology; Metadata,,"Computational Biology/methods; Databases, Genetic; Genomics; Software",,,http://europepmc.org/articles/PMC3172294/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172294/ https://pure.mpg.de/pubman/item/item_2484805_2/component/file_3264608/Hankeln11.PDF https://dx.plos.org/10.1371/journal.pone.0024797 http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0024797 https://paperity.org/p/61301621/cdinfusion-submission-ready-on-line-integration-of-sequence-and-contextual-data https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0024797 http://ui.adsabs.harvard.edu/abs/2011PLoSO...624797H/abstract https://core.ac.uk/display/152856330,http://dx.doi.org/10.1371/journal.pone.0024797,21935468,10.1371/journal.pone.0024797,1969935418,PMC3172294,0,003-179-962-154-708; 005-053-061-515-288; 006-043-193-943-45X; 009-005-868-049-133; 012-503-201-682-416; 021-934-855-776-260; 024-312-992-411-447; 024-841-374-797-219; 026-014-775-886-072; 032-243-295-012-217; 032-324-661-253-120; 045-984-330-229-025; 050-037-658-433-244; 050-190-801-373-266; 055-098-259-934-114; 057-309-284-415-818; 063-158-255-733-106; 068-697-673-980-091; 069-323-205-193-126; 081-093-653-163-637; 085-882-395-201-561; 112-240-033-624-754; 128-297-412-074-447,9,true,cc-by,gold
033-357-011-689-974,10 – Infectious Disease Genomics,,2017,book chapter,Genetics and Evolution of Infectious Diseases,,Elsevier,,Y.-T. Liu,"The history and development of infectious disease genomics have been closely associated with the Human Genome Project (HGP) during the past 20 years. It has been emphasized since the beginning of the HGP that such effort must not be restricted to the human genome and should include other organisms including mouse, bacteria, yeast, fruit fly, and worm for comparative sequence analyses. A brief history is reviewed in this chapter. As of 2016, more than 7000 completed genome sequencing projects have been reported. One of the important motivations for these efforts is to develop preventative, diagnostic, and therapeutic strategies through the analysis of sequenced microorganisms, parasites, and vectors related to human health. A number of examples are discussed in this chapter.",,,211,225,Genomics; Human genome; Human health; DNA sequencing; Infectious disease (medical specialty); Genetics; Biology,,,,,https://www.sciencedirect.com/science/article/pii/B978012799942500010X,http://dx.doi.org/10.1016/b978-0-12-799942-5.00010-x,,10.1016/b978-0-12-799942-5.00010-x,2589290597,,0,000-411-473-756-593; 001-037-464-650-921; 001-239-459-892-139; 001-375-822-977-96X; 001-437-814-415-087; 001-584-694-897-885; 002-324-631-927-739; 003-115-890-464-56X; 003-188-512-381-385; 003-448-933-145-40X; 005-200-872-026-047; 005-337-747-664-450; 006-030-785-051-284; 006-222-661-250-341; 006-636-105-513-278; 007-170-451-373-807; 007-386-355-549-983; 008-345-895-678-669; 008-646-643-771-647; 010-185-854-948-679; 010-616-651-746-497; 012-165-717-511-811; 012-825-142-417-621; 012-989-345-406-333; 013-913-142-716-118; 014-122-258-640-368; 014-534-795-281-314; 015-471-014-946-039; 016-274-316-812-849; 016-470-006-061-523; 016-509-090-704-506; 018-363-914-567-000; 019-404-540-235-136; 022-037-544-336-926; 022-587-399-297-604; 024-818-959-515-330; 025-184-271-920-869; 026-697-922-925-883; 026-840-090-408-080; 026-900-752-060-266; 027-095-783-245-21X; 028-121-405-222-902; 028-278-424-716-006; 028-845-852-943-051; 032-210-371-605-09X; 033-353-422-317-835; 033-653-023-305-639; 034-444-816-458-323; 034-752-844-669-616; 036-232-764-888-572; 036-463-242-765-952; 036-559-578-071-491; 036-744-943-054-847; 037-765-296-767-929; 038-270-711-499-952; 038-418-448-998-874; 038-553-755-377-818; 038-634-824-719-880; 040-171-457-010-143; 042-163-050-641-376; 042-944-931-083-652; 044-143-488-906-476; 044-723-266-881-69X; 044-738-504-821-409; 044-983-625-143-535; 045-718-647-707-484; 045-984-772-149-743; 046-875-080-460-868; 048-767-777-168-159; 051-630-951-539-439; 055-891-014-076-629; 056-484-705-117-491; 058-909-877-738-650; 061-385-147-951-672; 061-476-981-924-098; 063-252-343-472-533; 065-026-357-555-353; 067-453-943-043-94X; 067-941-336-437-579; 068-646-991-287-372; 069-124-051-052-66X; 069-454-032-054-100; 072-411-320-010-530; 072-468-715-449-932; 072-486-288-838-747; 072-985-767-078-737; 074-690-387-840-94X; 077-515-264-929-611; 077-754-382-431-169; 084-551-933-103-035; 089-291-432-133-58X; 089-665-675-580-150; 092-534-590-816-978; 095-254-063-868-138; 098-491-332-475-008; 111-572-812-561-056; 112-240-033-624-754; 114-235-222-696-307; 115-935-594-079-119; 116-184-802-287-572; 117-910-170-030-882; 119-273-136-697-716; 127-050-438-939-292; 135-843-892-483-782; 138-244-184-808-720; 141-594-099-106-247; 143-867-261-494-81X; 147-119-230-627-255; 152-056-487-808-890; 160-092-150-974-672; 165-045-523-049-130; 167-299-516-937-968; 183-839-942-877-122,0,true,,bronze
038-934-035-448-672,How Data Are Transforming the Landscape of Biomedical Ethics: The Need for ELSI Metadata on Consent,2016-08-04,2016,book chapter,"Law, Governance and Technology Series",23521902; 23521910,Springer International Publishing,,J. Patrick Woolley,"The Big Data vision for biomedicine supports compilation, long-term banking, and sharing of sensitive personal information, and potentially allows an individual’s data to be combined and utilised with other data indefinitely in innumerable research projects. But this vision does not adhere to the case-specific and jurisdiction-specific oversight models upon which current governance has been founded. Informed consent, for instance, a core principle of bioethics, no longer seems feasible as data repositories and Big Data methodologies become central to research. Policymakers have not yet found a consistent way to address ethical, legal, and social issues (ELSI) in this new data environment. Systematic ways of thinking are needed which reflect the new uses of biomedical data with a view toward upholding basic ELSI standards. The aim of this chapter is to present a view of governance where dataflow itself, not institutional or national boundaries, is taken as the de facto framework for research, and where metadata on consent play a central role in how data is governed. I identify types of consent as a place to begin to develop ELSI metadata procedures for data-enabled research contexts. Such metadata can assure data production, dissemination, and reuse is in accordance with participants’ and researchers’ expectations. Ultimately, it can assist with codification of criteria and standards that demonstrate impact of data intensive research along its ethical, legal, and social dimensions, at multiple levels of governance.",,,171,197,Personally identifiable information; Political science; Bioethics; Data science; Metadata standard; Corporate governance; Social issues; Engineering ethics; Informed consent; Big data; Metadata,,,,,https://link.springer.com/chapter/10.1007/978-3-319-33525-4_8/fulltext.html https://link.springer.com/chapter/10.1007/978-3-319-33525-4_8 https://rd.springer.com/chapter/10.1007/978-3-319-33525-4_8,http://dx.doi.org/10.1007/978-3-319-33525-4_8,,10.1007/978-3-319-33525-4_8,2479683044,,0,000-247-234-539-231; 004-613-862-207-388; 006-030-785-051-284; 007-625-054-956-978; 008-723-601-451-748; 016-282-408-493-072; 023-817-990-211-967; 025-456-891-173-338; 027-062-823-813-525; 036-069-898-162-219; 036-300-957-017-812; 041-816-561-565-570; 042-426-846-825-877; 044-939-394-642-346; 046-251-906-507-891; 047-491-166-136-739; 048-167-058-851-358; 048-400-890-581-411; 049-275-644-521-815; 050-969-179-014-018; 055-327-111-841-436; 059-419-119-019-002; 061-136-697-295-65X; 065-405-112-861-731; 074-583-970-000-784; 075-465-734-221-082; 077-787-103-639-778; 085-600-704-194-468; 094-722-172-647-367; 112-240-033-624-754; 122-122-135-402-189; 124-693-205-839-629; 125-810-717-283-966; 132-556-614-655-969; 133-349-617-354-963; 133-418-346-147-693; 137-695-449-324-702; 139-696-230-742-245; 164-227-941-473-162; 178-797-299-240-013; 191-594-863-321-721,6,false,,
047-792-354-561-678,EpiK: A Knowledge Base for Epidemiological Modeling and Analytics of Infectious Diseases,2017-11-06,2017,journal article,Journal of healthcare informatics research,25094971; 2509498x,Springer Science and Business Media LLC,Switzerland,S. M. Shamimul Hasan; Edward A. Fox; Keith R. Bisset; Madhav V. Marathe,"Computational epidemiology seeks to develop computational methods to study the distribution and determinants of health-related states or events (including disease), and the application of this study to the control of diseases and other health problems. Recent advances in computing and data sciences have led to the development of innovative modeling environments to support this important goal. The datasets used to drive the dynamic models as well as the data produced by these models presents unique challenges owing to their size, heterogeneity and diversity. These datasets form the basis of effective and easy to use decision support and analytical environments. As a result, it is important to develop scalable data management systems to store, manage and integrate these datasets. In this paper, we develop EpiK—a knowledge base that facilitates the development of decision support and analytical environments to support epidemic science. An important goal is to develop a framework that links the input as well as output datasets to facilitate effective spatio-temporal and social reasoning that is critical in planning and intervention analysis before and during an epidemic. The data management framework links modeling workflow data and its metadata using a controlled vocabulary. The metadata captures information about storage, the mapping between the linked model and the physical layout, and relationships to support services. EpiK is designed to support agent-based modeling and analytics frameworks—aggregate models can be seen as special cases and are thus supported. We use semantic web technologies to create a representation of the datasets that encapsulates both the location and the schema heterogeneity. The choice of RDF as a representation language is motivated by the diversity and growth of the datasets that need to be integrated. A query bank is developed—the queries capture a broad range of questions that can be posed and answered during a typical case study pertaining to disease outbreaks. The queries are constructed using SPARQL Protocol and RDF Query Language (SPARQL) over the EpiK. EpiK can hide schema and location heterogeneity while efficiently supporting queries that span the computational epidemiology modeling pipeline: from model construction to simulation output. We show that the performance of benchmark queries varies significantly with respect to the choice of hardware underlying the database and resource description framework (RDF) engine.",1,2,260,303,Decision support system; RDF; RDF Schema; Data science; Computer science; SPARQL; Knowledge base; Analytics; Metadata; RDF query language,Computational epidemiology; Knowledge base; Mapping; RDF; SPARQL; Social contact networks,,,,https://link.springer.com/article/10.1007/s41666-017-0010-9/fulltext.html https://link.springer.com/content/pdf/10.1007%2Fs41666-017-0010-9.pdf https://link.springer.com/article/10.1007/s41666-017-0010-9 https://dblp.uni-trier.de/db/journals/jhir/jhir1.html#HasanFBM17,http://dx.doi.org/10.1007/s41666-017-0010-9,35415398,10.1007/s41666-017-0010-9,2768055609,PMC8982844,0,000-713-840-510-311; 001-180-394-015-122; 002-398-746-188-624; 002-901-926-777-894; 003-793-651-735-214; 005-010-504-208-456; 007-352-874-218-371; 008-825-106-579-151; 009-641-362-691-505; 010-491-897-968-43X; 011-199-366-997-774; 016-104-673-071-805; 016-683-339-637-163; 024-866-809-066-046; 025-735-202-565-742; 026-039-430-885-657; 028-141-288-325-045; 029-838-004-406-596; 034-036-629-493-024; 035-219-025-550-161; 039-893-574-579-426; 040-296-971-663-63X; 040-528-595-566-923; 040-546-709-875-361; 042-334-625-445-039; 042-721-748-710-816; 043-755-866-475-361; 044-056-610-413-080; 049-828-271-564-288; 049-843-022-228-780; 053-700-081-869-613; 054-227-164-521-984; 057-701-214-888-309; 058-455-722-385-463; 058-922-541-610-481; 059-185-501-020-654; 059-968-029-428-453; 060-578-931-071-884; 060-588-101-806-65X; 063-524-778-480-811; 064-412-269-820-355; 067-967-488-043-718; 073-467-777-763-371; 074-259-913-430-249; 075-839-922-555-614; 078-796-561-177-452; 080-613-857-698-879; 080-715-899-618-950; 081-758-023-279-161; 083-728-973-677-193; 085-948-700-796-696; 086-028-560-475-384; 087-440-160-638-827; 093-248-454-261-401; 101-283-475-556-497; 107-132-106-144-171; 107-812-822-819-28X; 109-812-455-158-514; 112-240-033-624-754; 113-503-253-163-505; 115-660-423-442-972; 119-820-056-297-78X; 120-602-643-015-206; 127-917-837-110-026; 128-040-095-697-97X; 137-101-586-081-080; 144-036-442-946-626; 144-245-979-014-205; 149-016-215-691-655; 152-461-526-895-907; 153-993-169-208-382; 161-066-722-383-083; 163-680-866-249-978; 165-612-349-508-378; 171-816-698-904-899; 173-013-600-432-250; 184-383-844-373-282; 198-117-349-944-144,1,true,,green
049-343-662-542-46X,Infectious Disease Genomics,,2011,book chapter,Genetics and Evolution of Infectious Disease,,Elsevier,,Yu-Tsueng Liu,"Publisher Summary The history and development of infectious disease genomics are discussed in this chapter. HGP must not be restricted to the human genome and should include model organisms including mouse, bacteria, yeast, fruit fly, and worm. The completed or ongoing genome projects will provide enormous opportunities for the discovery of novel vaccines and drug targets against human pathogens as well as the improvement of diagnosis and discovery of infectious agents and the development of new strategies for invertebrate vector control. The polysaccharide capsule is important for meningococci to escape from complement-mediated killing. With the completion of the genome sequence of a virulent MenB strain, a “reverse vaccinology” approach was applied for the development of a universal MenB vaccine by Novartis. The indispensable fatty acid synthase (FAS) pathway in bacteria has been regarded as a promising target for the development of antimicrobial agents. Through a systematic screening of 250,000 natural product extracts, a Merck team identified a potent and broad-spectrum antibiotic, platensimycin, which is derived from Streptomyces platensis. Vector Biology Network was formed to achieve three goals (1) to develop basic tools for the stable transformation of anopheline mosquitoes by the year 2000; (2) to engineer a mosquito incapable of carrying the malaria parasite by 2005; and (3) to run controlled experiments to test how to drive the engineered genotype into wild mosquito populations by 2010. The most immediate impact of a completely sequenced pathogen genome is for infectious disease diagnosis.",,,249,261,Genome; Virology; Genomics; Model organism; Whole genome sequencing; Human pathogen; Reverse vaccinology; Infectious disease (medical specialty); Computational biology; Biology; Genome project,,,,,https://www.sciencedirect.com/science/article/pii/B9780123848901000108,http://dx.doi.org/10.1016/b978-0-12-384890-1.00010-8,,10.1016/b978-0-12-384890-1.00010-8,111783866,,0,000-411-473-756-593; 001-037-464-650-921; 001-239-459-892-139; 001-375-822-977-96X; 001-437-814-415-087; 001-584-694-897-885; 002-324-631-927-739; 003-115-890-464-56X; 003-188-512-381-385; 003-448-933-145-40X; 003-710-854-332-224; 004-653-726-716-301; 005-200-872-026-047; 005-337-747-664-450; 006-222-661-250-341; 006-636-105-513-278; 007-386-355-549-983; 008-646-643-771-647; 008-972-774-575-287; 010-185-854-948-679; 012-165-717-511-811; 012-989-345-406-333; 013-913-142-716-118; 014-534-795-281-314; 015-471-014-946-039; 016-274-316-812-849; 016-509-090-704-506; 018-363-914-567-000; 019-404-540-235-136; 022-037-544-336-926; 022-587-399-297-604; 024-818-959-515-330; 025-184-271-920-869; 026-697-922-925-883; 026-840-090-408-080; 026-900-752-060-266; 027-095-783-245-21X; 028-121-405-222-902; 028-278-424-716-006; 032-210-371-605-09X; 033-353-422-317-835; 033-653-023-305-639; 034-444-816-458-323; 034-752-844-669-616; 036-463-242-765-952; 036-559-578-071-491; 036-744-943-054-847; 037-765-296-767-929; 038-270-711-499-952; 038-418-448-998-874; 038-553-755-377-818; 038-634-824-719-880; 040-171-457-010-143; 042-163-050-641-376; 042-944-931-083-652; 043-391-337-502-219; 044-143-488-906-476; 044-723-266-881-69X; 044-983-625-143-535; 045-718-647-707-484; 045-984-772-149-743; 046-875-080-460-868; 048-767-777-168-159; 051-630-951-539-439; 052-600-362-643-085; 055-891-014-076-629; 058-909-877-738-650; 061-385-147-951-672; 061-712-638-905-561; 063-252-343-472-533; 065-026-357-555-353; 067-218-889-722-094; 067-453-943-043-94X; 067-941-336-437-579; 068-646-991-287-372; 069-124-051-052-66X; 069-454-032-054-100; 072-411-320-010-530; 072-468-715-449-932; 072-486-288-838-747; 074-690-387-840-94X; 077-515-264-929-611; 077-754-382-431-169; 084-551-933-103-035; 089-291-432-133-58X; 089-665-675-580-150; 092-534-590-816-978; 095-254-063-868-138; 098-491-332-475-008; 111-572-812-561-056; 112-240-033-624-754; 114-235-222-696-307; 115-935-594-079-119; 116-184-802-287-572; 117-910-170-030-882; 119-273-136-697-716; 135-843-892-483-782; 138-244-184-808-720; 141-594-099-106-247; 143-867-261-494-81X; 147-119-230-627-255; 152-056-487-808-890; 165-045-523-049-130; 167-299-516-937-968; 183-839-942-877-122,0,true,,bronze
049-749-466-421-855,Review of Geospatial Technology for Infectious Disease Surveillance: Use Case on COVID-19,2020-08-18,2020,journal article,Journal of the Indian Society of Remote Sensing,0255660x; 09743006,Springer Science and Business Media LLC,India,Sameer Saran; Priyanka Singh; Vishal Kumar; Prakash Chauhan,"This paper discusses on the increasing relevancy of geospatial technologies such as geographic information system (GIS) in the public health domain, particularly for the infectious disease surveillance and modelling strategies. Traditionally, the disease mapping tasks have faced many challenges—(1) authors rarely documented the evidence that were used to create map, (2) before evolution of GIS, many errors aroused in mapping tasks which were expanded extremely at global scales, and (3) there were no fidelity assessment of maps which resulted in inaccurate precision. This study on infectious diseases geo-surveillance is divided into four broad sections with emphasis on handling geographical and temporal issues to help in public health decision-making and planning policies: (1) geospatial mapping of diseases using its spatial and temporal information to understand their behaviour across geography; (2) the citizen’s involvement as volunteers in giving health and disease data to assess the critical situation for disease’s spread and prevention in neighbourhood effect; (3) scientific analysis of health-related behaviour using mathematical epidemiological and geo-statistical approaches with (4) capacity building program. To illustrate each theme, recent case studies are cited and case studies are performed on COVID-19 to demonstrate selected models.",48,8,1121,1138,Geomatics; Public health; Geography; Data science; Neighbourhood effect; Fidelity; Disease; Geographic information system; Infectious disease (medical specialty); Geospatial analysis,,,,,https://link.springer.com/article/10.1007/s12524-020-01140-5 https://doi.org/10.1007/s12524-020-01140-5 https://link.springer.com/content/pdf/10.1007/s12524-020-01140-5.pdf https://paperity.org/p/256131027/review-of-geospatial-technology-for-infectious-disease-surveillance-use-case-on-covid-19 https://covid19.elsevierpure.com/de/publications/review-of-geospatial-technology-for-infectious-disease-surveillan https://pubag.nal.usda.gov/catalog/7106178,http://dx.doi.org/10.1007/s12524-020-01140-5,,10.1007/s12524-020-01140-5,3049420798,,0,000-205-709-962-40X; 000-613-491-991-111; 000-948-836-106-937; 001-547-191-052-992; 001-775-042-221-291; 002-091-718-232-361; 002-595-147-873-972; 003-015-946-321-050; 003-552-004-178-848; 003-598-939-212-347; 003-746-752-666-690; 003-807-647-184-389; 003-860-975-044-185; 004-695-784-880-359; 004-872-180-828-888; 005-216-889-911-508; 005-379-041-545-762; 005-548-993-564-383; 005-920-094-272-561; 006-757-717-854-699; 008-382-296-324-562; 008-733-518-645-153; 008-925-507-603-317; 008-971-607-014-664; 009-163-146-779-787; 009-623-642-153-104; 011-832-152-840-369; 012-586-324-585-516; 013-213-264-713-348; 013-766-452-560-609; 013-837-737-101-444; 013-871-909-271-159; 015-327-033-554-595; 015-533-375-463-703; 015-556-022-314-202; 015-583-332-066-076; 016-489-187-666-344; 017-174-131-102-697; 017-808-669-846-083; 017-970-687-617-669; 018-154-804-302-596; 018-217-706-097-053; 018-715-049-768-76X; 018-852-350-263-85X; 019-849-496-353-718; 020-551-244-928-97X; 020-746-869-530-988; 020-955-060-035-924; 021-378-081-241-662; 021-537-129-492-168; 021-605-657-344-54X; 021-723-245-554-097; 022-111-333-383-346; 022-723-646-425-014; 022-723-989-130-306; 023-111-442-014-271; 024-982-561-486-693; 025-770-602-497-463; 025-799-703-968-227; 025-948-599-640-753; 026-717-415-335-614; 026-938-164-431-714; 027-492-636-392-008; 028-014-995-275-380; 029-318-296-887-379; 030-928-755-984-666; 032-903-495-847-439; 033-279-255-282-491; 033-285-694-158-231; 033-350-480-790-686; 033-478-517-813-056; 034-875-135-261-909; 035-526-584-758-030; 035-693-688-597-17X; 036-197-982-333-857; 036-349-746-123-84X; 036-439-754-405-889; 036-459-742-842-852; 036-722-986-046-786; 036-908-967-923-89X; 037-025-204-588-664; 037-398-594-174-118; 038-814-831-065-369; 038-910-803-076-28X; 039-670-494-229-639; 040-198-635-042-261; 040-208-209-256-79X; 040-400-169-904-253; 040-688-848-620-581; 040-692-269-309-424; 041-133-673-814-823; 041-328-617-459-089; 041-454-201-567-817; 041-631-857-152-563; 044-284-973-302-245; 045-522-104-696-681; 045-714-408-683-149; 045-919-401-020-878; 046-694-299-597-022; 047-730-223-199-45X; 048-506-970-705-82X; 049-114-239-365-209; 049-177-033-711-67X; 049-226-069-799-579; 049-259-109-284-483; 049-671-569-178-061; 049-713-897-724-140; 050-494-230-798-801; 051-318-514-276-638; 051-385-467-895-38X; 052-525-639-313-429; 053-383-109-588-631; 053-514-039-593-298; 054-570-085-193-263; 054-859-619-242-072; 054-982-489-699-499; 056-019-982-944-862; 057-545-918-303-995; 057-568-295-414-817; 057-818-086-904-288; 058-446-346-128-783; 059-398-195-656-230; 059-832-892-891-171; 059-924-296-005-784; 060-803-538-129-750; 060-904-646-192-397; 062-112-768-963-759; 062-299-674-201-940; 062-494-791-604-507; 062-847-294-417-832; 063-311-294-495-284; 063-365-044-739-294; 065-197-278-655-934; 065-535-325-590-096; 066-336-138-162-728; 069-774-631-576-851; 071-347-886-510-120; 071-403-187-935-385; 071-827-642-585-823; 073-616-054-509-325; 073-877-277-270-636; 073-933-979-355-750; 074-161-577-046-057; 074-743-375-158-800; 075-973-797-470-925; 076-531-241-686-542; 076-786-164-676-117; 076-863-036-625-717; 077-592-875-451-548; 080-781-080-752-233; 081-118-560-654-582; 082-278-123-566-84X; 082-585-649-210-506; 083-015-692-014-246; 083-131-431-018-60X; 083-314-678-099-116; 083-857-456-772-388; 084-273-687-308-627; 084-639-531-581-436; 085-221-214-334-157; 086-392-099-717-437; 088-248-020-798-374; 088-683-815-052-046; 088-695-958-872-98X; 090-616-311-866-654; 091-204-512-390-272; 091-483-645-060-925; 092-197-102-933-864; 092-569-055-448-595; 093-472-194-572-401; 094-513-579-105-913; 095-133-214-301-083; 097-500-998-966-60X; 099-012-659-209-356; 099-143-487-243-602; 099-675-327-872-917; 100-016-372-318-258; 100-174-367-058-352; 103-010-917-264-205; 103-081-387-145-206; 103-508-214-259-82X; 104-728-476-540-305; 105-526-458-827-311; 106-647-796-404-458; 107-386-240-532-220; 109-917-731-823-914; 109-954-781-425-036; 112-240-033-624-754; 114-465-236-116-346; 117-251-644-324-289; 117-735-565-335-108; 124-043-027-110-303; 124-369-399-879-957; 128-100-491-888-841; 128-132-282-797-392; 128-297-585-935-68X; 129-626-369-631-850; 133-967-299-042-160; 134-615-859-741-224; 136-971-465-201-210; 137-177-061-785-481; 138-026-010-237-061; 138-673-529-421-480; 139-325-050-108-201; 139-578-853-865-789; 143-979-193-746-101; 144-308-379-888-473; 146-076-690-511-890; 147-100-422-569-774; 152-964-406-780-827; 158-839-641-039-751; 159-960-934-746-119; 161-573-087-853-811; 165-315-509-728-716; 173-414-072-450-945; 173-801-968-534-455; 174-996-158-415-103; 190-316-875-318-451; 195-200-098-457-912,15,true,,bronze
070-356-971-977-33X,Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians.,2015-10-30,2015,journal article,Journal of Alzheimer's disease : JAD,18758908; 13872877,IOS Press,Netherlands,Sungeun Kim; Kwangsik Nho; Vijay K. Ramanan; Dongbing Lai; Tatiana Foroud; Katie Lane; Jill R. Murrell; Sujuan Gao; Kathleen S. Hall; Frederick W. Unverzagt; Olusegun Baiyewu; Adesola Ogunniyi; Oye Gureje; Mitchel A. Kling; P. Murali Doraiswamy; Rima Kaddurah-Daouk; Hugh C. Hendrie; Andrew J. Saykin,"Plasma homocysteine, a metabolite involved in key cellular methylation processes seems to be implicated in cognitive functions and cardiovascular health with its high levels representing a potential modifiable risk factor for Alzheimer's disease (AD) and other dementias. A better understanding of the genetic factors regulating homocysteine levels, particularly in non-white populations, may help in risk stratification analyses of existing clinical trials and may point to novel targets for homocysteine-lowering therapy. To identify genetic influences on plasma homocysteine levels in individuals with African ancestry, we performed a targeted gene and pathway-based analysis using a priori biological information and then to identify new association performed a genome-wide association study. All analyses used combined data from the African American and Yoruba cohorts from the Indianapolis-Ibadan Dementia Project. Targeted analyses demonstrated significant associations of homocysteine and variants within the CBS (Cystathionine beta-Synthase) gene. We identified a novel genome-wide significant association of the AD risk gene CD2AP (CD2-associated protein) with plasma homocysteine levels in both cohorts. Minor allele (T) carriers of identified CD2AP variant (rs6940729) exhibited decreased homocysteine level. Pathway enrichment analysis identified several interesting pathways including the GABA receptor activation pathway. This is noteworthy given the known antagonistic effect of homocysteine on GABA receptors. These findings identify several new targets warranting further investigation in relation to the role of homocysteine in neurodegeneration.",49,4,991,1003,Genome-wide association study; Minor allele frequency; Cystathionine beta synthase; Homocysteine; Disease; Dementia; Risk factor; Genetics; Bioinformatics; Genetic variation; Biology,African Continental Ancestry Group; CD2-associated protein; cystathionine beta-synthase; genome-wide association study; homocysteine; metabolic networks and pathways; metabolomics,"Adaptor Proteins, Signal Transducing/genetics; African Americans/genetics; Aged; Aged, 80 and over; Blacks/genetics; Cohort Studies; Cystathionine beta-Synthase/genetics; Cytoskeletal Proteins/genetics; Female; Genetic Variation; Genome-Wide Association Study; Heterozygote; Homocysteine/blood; Humans; Indiana; Longitudinal Studies; Male; Nigeria; Prospective Studies","Adaptor Proteins, Signal Transducing; CD2-associated protein; Cytoskeletal Proteins; Homocysteine; Cystathionine beta-Synthase",NIA NIH HHS (R01 AG019771) United States; NLM NIH HHS (R00 LM011384) United States; NIA NIH HHS (P30 AG10133) United States; NIA NIH HHS (P30 AG010133) United States; NIA NIH HHS (R01 AG009956) United States; NLM NIH HHS (R01 LM011360) United States; NIA NIH HHS (AG19771) United States; NIA NIH HHS (R03 AG050856) United States; NIA NIH HHS (R01 AG09956) United States; NLM NIH HHS (R00LM011384) United States,https://www.medra.org/servlet/aliasResolver?alias=iospress&doi=10.3233/JAD-150651 https://content.iospress.com/articles/journal-of-alzheimers-disease/jad150651 https://www.ncbi.nlm.nih.gov/pubmed/26519441 http://doi.org/10.3233/JAD-150651 https://europepmc.org/article/PMC/PMC4822513 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822513/ https://doi.org/10.3233/JAD-150651 https://core.ac.uk/download/81633909.pdf,http://dx.doi.org/10.3233/jad-150651,26519441,10.3233/jad-150651,1958017112,PMC4822513,0,000-758-525-350-150; 001-541-989-627-911; 001-664-989-439-451; 002-235-646-263-045; 002-521-435-196-572; 002-958-353-990-563; 004-470-164-157-453; 006-193-818-738-944; 006-635-819-665-420; 006-825-063-320-648; 006-850-845-527-699; 010-529-237-209-914; 010-643-346-919-56X; 010-836-224-276-886; 010-878-189-062-991; 011-528-891-017-257; 013-309-210-921-340; 014-822-666-343-124; 015-715-136-840-230; 015-773-781-698-084; 017-884-908-415-331; 020-400-878-161-506; 020-439-430-668-665; 022-057-276-882-821; 022-146-775-872-139; 022-572-932-698-317; 023-551-167-806-037; 025-199-292-086-983; 028-083-478-415-882; 031-887-913-314-325; 032-418-418-589-449; 032-871-447-670-145; 034-009-529-982-628; 034-776-724-346-157; 035-393-161-203-82X; 036-628-206-072-529; 037-060-419-804-970; 037-568-480-865-710; 040-175-838-267-231; 043-169-762-487-673; 043-431-395-354-860; 046-534-149-747-723; 052-607-522-564-135; 053-284-513-382-682; 056-123-984-082-186; 056-352-765-539-085; 058-705-305-953-844; 060-662-388-805-314; 061-898-439-846-042; 062-077-343-975-091; 063-855-484-526-227; 063-991-004-452-975; 065-212-812-028-221; 068-118-552-932-369; 068-676-131-709-712; 068-904-024-959-136; 070-293-730-598-587; 070-528-626-971-904; 071-240-627-858-982; 071-517-363-796-341; 072-313-676-885-558; 073-884-772-539-247; 076-151-942-036-783; 078-649-681-127-193; 079-337-326-982-201; 081-151-720-398-245; 082-284-524-184-712; 088-346-347-420-663; 088-602-718-460-26X; 092-659-968-037-300; 099-065-724-291-51X; 100-094-315-719-059; 101-950-823-882-851; 102-046-065-990-52X; 102-662-282-114-744; 104-262-378-350-338; 107-091-335-590-425; 108-170-506-572-902; 110-166-722-414-378; 112-240-033-624-754; 130-721-103-517-744; 140-851-783-904-569; 148-395-439-984-410; 153-981-565-926-353; 154-115-174-594-852,10,true,,green
082-243-214-348-506,Disease Ontology: a backbone for disease semantic integration,2011-11-12,2011,journal article,Nucleic acids research,13624962; 03051048,Oxford University Press,United Kingdom,Lynn M. Schriml; Cesar Arze; Suvarna Nadendla; Yu-Wei Wayne Chang; Mark J. Mazaitis; Victor Felix; Gang Feng; Warren A. Kibbe,"The Disease Ontology (DO) database (http://disease-ontology.org) represents a comprehensive knowledge base of 8043 inherited, developmental and acquired human diseases (DO version 3, revision 2510). The DO web browser has been designed for speed, efficiency and robustness through the use of a graph database. Full-text contextual searching functionality using Lucene allows the querying of name, synonym, definition, DOID and cross-reference (xrefs) with complex Boolean search strings. The DO semantically integrates disease and medical vocabularies through extensive cross mapping and integration of MeSH, ICD, NCI's thesaurus, SNOMED CT and OMIM disease-specific terms and identifiers. The DO is utilized for disease annotation by major biomedical databases (e.g. Array Express, NIF, IEDB), as a standard representation of human disease in biomedical ontologies (e.g. IDO, Cell line ontology, NIFSTD ontology, Experimental Factor Ontology, Influenza Ontology), and as an ontological cross mappings resource between DO, MeSH and OMIM (e.g. GeneWiki). The DO project (http://diseaseontology.sf.net) has been incorporated into open source tools (e.g. Gene Answers, FunDO) to connect gene and disease biomedical data through the lens of human disease. The next iteration of the DO web browser will integrate DO's extended relations and logical definition representation along with these biomedical resource cross-mappings.",40,Database issue,940,946,Semantic integration; Open Biomedical Ontologies; SNOMED CT; Ontology-based data integration; Information retrieval; Ontology; Disease Ontology; Experimental factor ontology; Bioinformatics; Upper ontology; Biology,,"Computer Graphics; Databases, Factual; Disease/classification; Humans; Semantics; Software; Terminology as Topic; User-Computer Interface; Vocabulary, Controlled",,NCRR NIH HHS (UL1 RR025741) United States; NCRR NIH HHS (R01RR025342) United States,https://www.ncbi.nlm.nih.gov/sites/ppmc/articles/PMC3245088/ http://europepmc.org/abstract/MED/22080554 https://paperity.org/p/34539971/disease-ontology-a-backbone-for-disease-semantic-integration https://www.researchgate.net/profile/Warren_Kibbe/publication/51796080_Disease_Ontology_a_backbone_for_disease_semantic_integration/links/00b7d525da84af07b4000000.pdf https://academic.oup.com/nar/article/40/D1/D940/2903651 https://dblp.uni-trier.de/db/journals/nar/nar40.html#SchrimlANCMFFK12 http://nar.oxfordjournals.org/content/40/D1/D940.long https://pubmed.ncbi.nlm.nih.gov/22080554/ https://europepmc.org/articles/PMC3245088 https://doi.org/10.1093/nar/gkr972 http://dx.doi.org/10.1093/nar/gkr972 http://pubmed.ncbi.nlm.nih.gov/22080554/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245088/ http://nar.oxfordjournals.org/content/40/D1/D940.full.pdf+html https://dx.doi.org/10.1093/nar/gkr972,http://dx.doi.org/10.1093/nar/gkr972,22080554,10.1093/nar/gkr972,2159092541,PMC3245088,6,001-437-814-415-087; 006-410-513-314-68X; 011-831-311-825-058; 013-073-632-111-26X; 017-425-533-825-963; 018-967-229-298-938; 022-347-037-241-010; 023-441-309-684-622; 027-395-104-481-603; 031-013-307-062-052; 035-049-620-990-875; 046-349-456-344-014; 047-843-912-914-122; 054-270-010-924-565; 061-617-664-558-764; 062-190-817-440-625; 077-417-551-711-616; 078-456-102-890-274; 084-568-012-088-53X; 095-227-789-396-359; 098-464-500-981-732; 103-284-714-649-912; 112-240-033-624-754; 113-308-406-790-347; 120-829-522-181-781; 121-311-380-693-131; 141-796-470-058-514; 158-084-170-405-184,690,true,"CC BY, CC BY-NC",gold
089-130-812-755-981,NIASGBdb: NIAS Genebank databases for genetic resources and plant disease information,2010-10-14,2010,journal article,Nucleic acids research,13624962; 03051048,Oxford University Press,United Kingdom,Masaru Takeya; Fukuhiro Yamasaki; Shihomi Uzuhashi; Takayuki Aoki; Hiroyuki Sawada; Toshirou Nagai; Keisuke Tomioka; Norihiko Tomooka; Toyozo Sato; Makoto Kawase,"The National Institute of Agrobiological Sciences (NIAS) is implementing the NIAS Genebank Project for conservation and promotion of agrobiological genetic resources to contribute to the development and utilization of agriculture and agricultural products. The project's databases (NIASGBdb; http://www.gene.affrc.go.jp/databases_en.php) consist of a genetic resource database and a plant diseases database, linked by a web retrieval database. The genetic resources database has plant and microorganism search systems to provide information on research materials, including passport and evaluation data for genetic resources with the desired properties. To facilitate genetic diversity research, several NIAS Core Collections have been developed. The NIAS Rice (Oryza sativa) Core Collection of Japanese Landraces contains information on simple sequence repeat (SSR) polymorphisms. SSR marker information for azuki bean (Vigna angularis) and black gram (V. mungo) and DNA sequence data from some selected Japanese strains of the genus Fusarium are also available. A database of plant diseases in Japan has been developed based on the listing of common names of plant diseases compiled by the Phytopathological Society of Japan. Relevant plant and microorganism genetic resources are associated with the plant disease names by the web retrieval database and can be obtained from the NIAS Genebank for research or educational purposes.",39,Database issue,1108,1113,Agriculture; Biotechnology; Genetic marker; Diseases database; Web retrieval; Genetic resources; Plant disease; Genetic variation; Database; Genetic diversity; Biology,,"Crops, Agricultural/genetics; DNA, Fungal/chemistry; Databases, Genetic; Fusarium/genetics; Genetic Markers; Genetic Variation; Plant Diseases/microbiology","DNA, Fungal; Genetic Markers",,https://dblp.uni-trier.de/db/journals/nar/nar39.html#TakeyaYUASNTTSK11 http://nar.oxfordjournals.org/content/39/suppl_1/D1108.full.pdf http://dx.doi.org/10.1093/nar/gkq916 https://dx.doi.org/10.1093/nar/gkq916 https://core.ac.uk/display/105496407 https://academic.oup.com/nar/article/39/suppl_1/D1108/2508610 https://academic.oup.com/nar/article/39/suppl_1/D1108/2508610/NIASGBdb-NIAS-Genebank-databases-for-genetic https://www.ncbi.nlm.nih.gov/pubmed/20952407 https://paperity.org/p/34584328/niasgbdb-nias-genebank-databases-for-genetic-resources-and-plant-disease-information https://europepmc.org/articles/PMC3013781/,http://dx.doi.org/10.1093/nar/gkq916,20952407,10.1093/nar/gkq916,2111734812,PMC3013781,0,001-435-004-316-264; 004-067-234-292-141; 011-706-843-145-755; 012-066-460-747-146; 022-241-951-137-578; 028-396-206-548-224; 039-164-316-302-002; 039-506-917-444-900; 043-488-012-861-150; 045-275-616-899-663; 092-736-848-630-35X; 094-834-647-980-670; 112-240-033-624-754; 131-839-917-343-296; 147-297-783-312-597; 191-707-190-001-632,24,true,"CC BY, CC BY-NC",gold
097-767-547-325-208,Towards Structuring Unstructured GenBank Metadata for Enhancing Comparative Biological Studies.,2011-03-07,2011,journal article,AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science,21534063,,United States,Elizabeth S. Chen; Indra Neil Sarkar,"Within large sequence repositories such as GenBank there is a wealth of metadata providing contextual information that may enhance search and retrieval of relevant sequences for a range of subsequent analyses. One challenge is the use of free-text in these metadata fields where approaches are needed to extract, structure, and encode essential information. The goal of the present study was to explore the feasibility of using a combination of existing resources for annotating unstructured GenBank metadata, initially focusing on the “host” and “isolation_source” fields. This paper summarizes early results for 10 host organisms that include a characterization of associated isolation sources with respect to biomedical ontologies and semantic types. The findings from this preliminary study provide insights to the rich amount of information captured within these unstructured metadata, guidance for addressing the challenges and issues encountered, and highlight the potential value for enriching comparative biological studies towards improving human health.",2011,,6,10,Open Biomedical Ontologies; Structure (mathematical logic); Host (network); Isolation (database systems); Information retrieval; Structuring; Computer science; ENCODE; GenBank; Metadata,,,,NLM NIH HHS (R01 LM009725) United States,http://europepmc.org/articles/PMC3248757 https://www.ncbi.nlm.nih.gov/pubmed/22211174,https://www.ncbi.nlm.nih.gov/pubmed/22211174,22211174,,1961588674,PMC3248757,0,001-437-814-415-087; 008-895-861-187-411; 009-005-868-049-133; 024-312-992-411-447; 027-395-104-481-603; 030-949-166-132-732; 042-659-823-190-298; 060-588-101-806-65X; 064-808-719-827-310; 080-145-884-015-119; 081-344-468-188-553; 112-240-033-624-754; 177-138-245-414-473,4,true,,
119-755-856-021-812,IRI - Toward Semantic Search for the Biogeochemical Literature,,2017,conference proceedings article,2017 IEEE International Conference on Information Reuse and Integration (IRI),,IEEE,,Joshua D. Eisenberg; Deya Banisakher; Maria Presa; Kalli Unthank; Mark A. Finlayson; René M. Price; Shu-Ching Chen,"Literature search is a vital step of every research project. Semantic literature search is an approach to article retrieval and ranking using concepts rather than keywords, in an attempt to address the well-known deficiencies of keyword-based search, namely, (1) retrieval of an overwhelming number of results, (2) rankings that do not precisely reflect true relevance, and (3) the omission of relevant results because they do not contain the idiosyncratic keywords of the query. The difficulty of semantic search, however, is that it requires significant knowledge engineering, often in the form of conceptual ontologies tailored to a particular scientific domain. It also requires non-trivial tuning, in the form of domain-specific term and concepts weights. Here we present preliminary, work-in-progress results in the development of a semantic search system for the biogeochemical scientific literature. We report the following initial steps: first, one of the co-authors—a biogeochemistry expert—wrote a sample search query, and ranked the five most relevant articles that were returned for that query from a popular keyword-based search engine. We then hand annotated the five articles and the query with the Environmental Ontology (ENVO), an existing ontology for the domain. Critically, this pilot annotation revealed a number of missing concepts that we will add in future work. We then showed that a straightforward ontology distance metric between concepts in the search query and the five articles was sufficient to produce the expected ranking. We discuss the implications of these results, and outline next steps required produce a full-fledged semantic search system for the biogeochemistry scientific literature.",,,517,525,Search analytics; Web search query; Semantic search; Ontology (information science); Concept search; Information retrieval; Scientific literature; Phrase search; Computer science; Query expansion,,,,,https://ieeexplore.ieee.org/document/8102978/ https://dblp.uni-trier.de/db/conf/iri/iri2017.html#EisenbergBRUFPC17,http://dx.doi.org/10.1109/iri.2017.49,,10.1109/iri.2017.49,2768495696,,0,004-446-332-271-977; 011-241-717-579-539; 014-385-306-604-535; 015-590-928-776-066; 018-203-096-520-098; 023-827-495-739-413; 026-259-712-932-233; 042-804-479-209-954; 043-486-392-808-079; 045-163-375-516-257; 048-086-183-175-411; 055-709-566-196-991; 059-645-631-899-796; 062-161-675-998-662; 062-213-533-624-448; 075-833-304-920-488; 077-719-362-591-268; 081-282-094-792-367; 082-660-019-426-780; 086-747-172-728-010; 097-494-112-757-262; 099-766-141-639-950; 101-448-401-819-349; 112-240-033-624-754; 122-720-708-824-937; 133-865-540-546-561; 135-459-425-887-44X; 153-660-149-561-087; 174-317-175-738-222; 177-175-750-040-989,2,false,,
136-288-669-107-676,"The Pathogen-annotated Tracking Resource Network (PATRN) system: A web-based resource to aid food safety, regulatory science, and investigations of foodborne pathogens and disease",2013-01-23,2013,journal article,Food microbiology,10959998; 07400020,Academic Press Inc.,United States,Gopal R. Gopinath; K. Hari; R. Jain; Mark K. Mammel; Mahendra H. Kothary; Augusto A. Franco; Christopher J. Grim; K. G. Jarvis; Venugopal Sathyamoorthy; Lan Hu; Atin R. Datta; Isha R. Patel; Scott A. Jackson; Jayanthi Gangiredla; Michael L. Kotewicz; Joseph E. LeClerc; M. Wekell; B. A. McCardell; M. D. Solomotis; Ben D. Tall,"Abstract Investigation of foodborne diseases requires the capture and analysis of time-sensitive information on microbial pathogens that is derived from multiple analytical methods and sources. The web-based Pathogen-annotated Tracking Resource Network (PATRN) system ( www.patrn.net ) was developed to address the data aggregation, analysis, and communication needs important to the global food safety community for the investigation of foodborne disease. PATRN incorporates a standard vocabulary for describing isolate metadata and provides a representational schema for a prototypic data exchange standard using a novel data loading wizard for aggregation of assay and attribution information. PATRN currently houses expert-curated, high-quality “foundational datasets” consisting of published experimental results from conventional assays and next generation analysis platforms for isolates of Escherichia coli , Listeria monocytogenes , and Salmonella , Shigella , Vibrio and Cronobacter species. A suite of computational tools for data mining, clustering, and graphical representation is available. Within PATRN, the public curated data repository is complemented by a secure private workspace for user-driven analyses, and for sharing data among collaborators. To demonstrate the data curation, loading wizard features, and analytical capabilities of PATRN, three use-case scenarios are presented. Use-case scenario one is a comparison of the distribution and prevalence of plasmid-encoded virulence factor genes among 249 Cronobacter strains with similar attributes to that of nine Cronobacter isolates from recent cases obtained between March and October, 2010–2011. To highlight PATRN's data management and trend finding tools, analysis of datasets, stored in PATRN as part of an ongoing surveillance project to identify the predominant molecular serogroups among Cronobacter sakazakii isolates observed in the USA is shown. Use-case scenario two demonstrates the secure workspace available for private users to upload and analyze sensitive data, and for collating cross-platform datasets to identify and validate congruent datapoints. SNP datasets from WGS assemblies and pan-genome microarrays are analyzed in a combinatorial fashion to determine relatedness of 33 Salmonella enterica strains to six strains collected as part of an outbreak investigation. Use-case scenario three utilizes published surveillance results that describe the incidence and sources of O157:H7 E. coli isolates associated with a produce pre-harvest surveillance study that occurred during 2002–2006. In summary, PATRN is a web-based integrated platform containing tools for the management, analysis and visualization of data about foodborne pathogens.",34,2,303,318,Data exchange; Data management; Data science; Cronobacter sakazakii; Cronobacter; Information repository; Data aggregator; Biology; Microbiology; Data curation; Metadata,,Bacteria/classification; Data Mining; Database Management Systems/instrumentation; Food Microbiology; Food Safety/methods; Foodborne Diseases/microbiology; Humans; Information Dissemination; Information Services/instrumentation; Internet,,,https://www.sciencedirect.com/science/article/pii/S0740002013000026 https://www.ncbi.nlm.nih.gov/pubmed/23541197 https://www.cabdirect.org/cabdirect/abstract/20133168131,http://dx.doi.org/10.1016/j.fm.2013.01.001,23541197,10.1016/j.fm.2013.01.001,2114269092,,0,001-437-814-415-087; 001-903-689-381-652; 004-026-226-983-371; 004-045-907-370-339; 004-184-940-485-832; 004-366-517-549-162; 005-983-067-650-828; 007-118-610-277-663; 008-231-969-308-228; 008-748-602-939-156; 011-874-787-988-696; 013-059-630-635-640; 015-225-493-695-535; 015-930-489-228-313; 016-315-130-217-847; 016-812-841-007-907; 018-022-852-313-834; 021-514-897-004-954; 021-762-955-946-871; 021-874-228-188-564; 022-914-664-076-85X; 024-645-901-447-985; 025-934-708-849-189; 028-177-541-834-228; 028-381-637-879-138; 028-508-265-170-595; 029-640-505-327-016; 030-203-232-825-14X; 031-206-254-111-586; 031-449-512-924-376; 032-038-499-313-625; 032-401-573-898-929; 033-207-846-396-973; 035-413-713-963-081; 038-708-737-994-795; 038-842-672-177-475; 041-891-714-950-585; 044-892-489-930-214; 046-942-381-097-289; 047-570-390-544-636; 056-167-312-153-409; 056-870-310-103-808; 057-901-192-811-824; 059-333-983-697-298; 062-967-696-369-024; 063-058-095-060-441; 066-166-021-966-07X; 066-586-957-648-010; 076-985-187-928-059; 079-740-016-321-387; 081-589-879-516-422; 083-874-058-446-063; 100-840-528-972-746; 103-372-615-010-793; 109-295-070-588-457; 112-240-033-624-754; 118-543-793-180-814; 132-370-308-081-244; 146-225-248-240-852; 186-935-818-527-298,10,false,,
